Counterfeit and substandard amodiaquine formulations in Papua New Guinea (PNG)
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: NAIR, Anita (Department of Pharmaceutical Technology, Johann Wolfgang Goethe University, Frankfurt Am Main, Germany)
- Co-author(s): Strauch, Stefanie (Johann Wolfgang Goethe University, FRANKFURT AM MAIN, Germany)
Lauwo, Jackson (University of Papua New Guinea, PORT MORESBY, Papua New Guinea)
Dressman, Jennifer (Johann Wolfgang Goethe University, FRANKFURT AM MAIN, Germany)
Background Information: Poor quality medicines particularly affect lower income countries where information and drug regulation enforcement is scant or absent. It is logical that any effort to treat and control common life threatening diseases will be futile if counterfeit or substandard medicines are used. Malaria is the leading cause of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.